These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6960809)

  • 21. Effect of leucotrienes C4, D4, prostacyclin and thromboxane A2 on isolated human cerebral arteries.
    von Holst H; Granström E; Hammarström S; Samuelsson B; Steiner L
    Acta Neurochir (Wien); 1982; 62(3-4):177-85. PubMed ID: 7048861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute infusion of nicotine potentiates norepinephrine-induced vasoconstriction in the hamster cheek pouch.
    Mayhan WG
    J Lab Clin Med; 1999 Jan; 133(1):48-54. PubMed ID: 10385481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of carbocyclic thromboxane A2 and its interaction with prostaglandin I2 and verapamil in isolated arteries.
    Toda N
    Circ Res; 1982 Dec; 51(6):675-82. PubMed ID: 6754126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbocyclic thromboxane A2: aggrevation of myocardial ischemia by a new synthetic thromboxane A2 analog.
    Smith EF; Lefer AM; Aharony D; Smith JB; Magolda RL; Claremon D; Nicolaou KC
    Prostaglandins; 1981 Mar; 21(3):443-56. PubMed ID: 7232768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
    Shibata S; Ho WK; Ishida U
    J Pharmacol Exp Ther; 1980 Nov; 215(2):357-62. PubMed ID: 7441499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity in the response to vasoconstrictors of isolated dog proximal and distal middle cerebral arteries.
    Toda N; Okamura T; Miyazaki M
    Eur J Pharmacol; 1984 Nov; 106(2):291-9. PubMed ID: 6597776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of prostaglandin H2 and thromboxane A2 with human serum albumin.
    Maclouf J; Kindahl H; Granström E; Samuelsson B
    Eur J Biochem; 1980 Aug; 109(2):561-6. PubMed ID: 7408901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
    Patscheke H; Stegmeier K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives.
    Roth DM; Lefer AM; Smith JB; Nicolaou KC
    Prostaglandins Leukot Med; 1982 Nov; 9(5):503-9. PubMed ID: 6960376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action of prostaglandins, endoperoxides, and thromboxanes on the lamb ductus arteriosus.
    Coceani F; Bishai I; White E; Bodach E; Olley PM
    Am J Physiol; 1978 Feb; 234(2):H117-22. PubMed ID: 623311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action.
    Dillon PK; Ritter AB; Durán WN
    Circ Res; 1988 Apr; 62(4):722-31. PubMed ID: 2832096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 16-p-fluorophenoxy prostanoid with potent and long-lasting thromboxane-like actions [proceedings].
    Jones RL; Wilson NH
    Br J Pharmacol; 1978 Jun; 63(2):362P. PubMed ID: 667444
    [No Abstract]   [Full Text] [Related]  

  • 33. Prostaglandins and uterine contractility.
    Wiqvist N; Lindblom B; Wikland M; Wilhelmsson L
    Acta Obstet Gynecol Scand Suppl; 1983; 113():23-9. PubMed ID: 6574679
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable carbocyclic analog of thromboxane A2 as antagonist of prostaglandin receptors.
    Shimizu K; Kohli JD; Goldberg LI; Kittisopikul S; Fried J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():333-6. PubMed ID: 6303072
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanism of coronary vasoconstriction induced by carbocyclic thromboxane A2.
    Smith EF; Lefer AM; Nicolaou KC
    Am J Physiol; 1981 Apr; 240(4):H493-7. PubMed ID: 6261592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide.
    Tesfamariam B
    J Hypertens; 1994 Jan; 12(1):41-7. PubMed ID: 8157943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of TMB-8 on the pulmonary vasoconstrictor action of prostaglandin F2 alpha and the thromboxane mimic, U 46619.
    Angerio AD; Fitzpatrick TM; Kot PA; Ramwell PW; Rose JC; Santoian EC
    Br J Pharmacol; 1982 Sep; 77(1):55-8. PubMed ID: 6957253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.